Vigil Neuroscience Statistics
Total Valuation
VIGL has a market cap or net worth of $123.73 million. The enterprise value is $25.64 million.
Important Dates
The next estimated earnings date is Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIGL has 40.83 million shares outstanding. The number of shares has increased by 3.41% in one year.
| Current Share Class | 40.83M |
| Shares Outstanding | 40.83M |
| Shares Change (YoY) | +3.41% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.05% |
| Owned by Institutions (%) | 41.13% |
| Float | 22.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.72 |
| Quick Ratio | 3.66 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -73.62% and return on invested capital (ROIC) is -43.93%.
| Return on Equity (ROE) | -73.62% |
| Return on Assets (ROA) | -38.06% |
| Return on Invested Capital (ROIC) | -43.93% |
| Return on Capital Employed (ROCE) | -87.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.20M |
| Employee Count | 69 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.57% in the last 52 weeks. The beta is 1.85, so VIGL's price volatility has been higher than the market average.
| Beta (5Y) | 1.85 |
| 52-Week Price Change | -2.57% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 3.23 |
| Relative Strength Index (RSI) | 77.87 |
| Average Volume (20 Days) | 642,495 |
Short Selling Information
The latest short interest is 1.81 million, so 4.44% of the outstanding shares have been sold short.
| Short Interest | 1.81M |
| Short Previous Month | 736,514 |
| Short % of Shares Out | 4.44% |
| Short % of Float | 8.20% |
| Short Ratio (days to cover) | 0.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -88.43M |
| Pretax Income | -82.78M |
| Net Income | -82.60M |
| EBITDA | -87.97M |
| EBIT | -88.43M |
| Earnings Per Share (EPS) | -$2.07 |
Full Income StatementBalance Sheet
The company has $111.27 million in cash and $13.18 million in debt, giving a net cash position of $98.09 million or $2.40 per share.
| Cash & Cash Equivalents | 111.27M |
| Total Debt | 13.18M |
| Net Cash | 98.09M |
| Net Cash Per Share | $2.40 |
| Equity (Book Value) | 88.55M |
| Book Value Per Share | 2.23 |
| Working Capital | 83.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.59 million and capital expenditures -$18,000, giving a free cash flow of -$48.61 million.
| Operating Cash Flow | -48.59M |
| Capital Expenditures | -18,000 |
| Free Cash Flow | -48.61M |
| FCF Per Share | -$1.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |